{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:15:21Z","timestamp":1778926521513,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.vhri.2016.01.003","type":"journal-article","created":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T04:05:30Z","timestamp":1459915530000},"page":"42-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cost-Effectiveness of the Quantification of Enzymatic Activity in Leukocytes in Comparison to Its Nonrealization for a Rare Disease in Latin America: The Case of Mucopolysaccharidosis Type II in Colombia"],"prefix":"10.1016","volume":"11","author":[{"given":"Elizabeth","family":"Parody","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"A. Guevara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"M. Tello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vhri.2016.01.003_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-6-72","article-title":"Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease","volume":"6","author":"Scarpa","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.vhri.2016.01.003_bib2","series-title":"Detecci\u00f3n precoz de mucopolisacaridosis y oligosacaridosis en el per\u00edodo neonatal mediante cribado poblacional. Revisi\u00f3n sistem\u00e1tica","author":"Maceira Rozas MC","year":"2006"},{"key":"10.1016\/j.vhri.2016.01.003_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1590\/S1415-47572014000300003","article-title":"Guidelines for diagnosis and treatment of Hunter syndrome for clinicians in Latin America","volume":"37","author":"Giugliani","year":"2014","journal-title":"Genet Mol Biol"},{"key":"10.1016\/j.vhri.2016.01.003_bib4","first-page":"602","article-title":"Estimaci\u00f3n de las frecuencias de las mucopolisacaridosis y an\u00e1lisis de agrupamiento espacial en los departamentos de Cundinamarca y Boyac\u00e1","volume":"2","author":"G\u00f3mez","year":"2012","journal-title":"Biom\u00e9dica"},{"key":"10.1016\/j.vhri.2016.01.003_bib5","first-page":"377","article-title":"Estudios bioqu\u00edmicos de los errores innatos del metabolismo en Colombia durante dos d\u00e9cadas","volume":"33","author":"Barrera-Avellaneda","year":"2009","journal-title":"Rev Acad Colomb Cienc"},{"key":"10.1016\/j.vhri.2016.01.003_bib6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00431-012-1703-y","article-title":"Diagnosing Hunter syndrome in pediatric practice: practical considerations and common pitfalls","volume":"171","author":"Burton","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vhri.2016.01.003_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1542\/peds.2007-1350","article-title":"Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome)","volume":"121","author":"Martin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.vhri.2016.01.003_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16390","article-title":"The effectiveness and cost of enzyme replacement and substrate reduction therapies: a longitudinal cohort study of people with lysosomal storage disorders","volume":"16","author":"Wyatt","year":"2012","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.vhri.2016.01.003_bib9","unstructured":"Instituto de Evaluaci\u00f3n Tecnol\u00f3gica en Salud (IETS). Manual para la elaboraci\u00f3n de evaluaciones econ\u00f3micas en salud. 2014. Available from: \u3008http:\/\/www.iets.org.co\/Manuales\/Manuales\/Manual%20evaluacio%CC%81n%20econo%CC%81mica%20web%2030%20sep.pdf\u3009. [Accessed July 17, 2014]."},{"key":"10.1016\/j.vhri.2016.01.003_bib10","first-page":"175","article-title":"Gu\u00eda para el diagn\u00f3stico, seguimiento y tratamiento de la mucopolisacaridosis tipo II o enfermedad de Hunter","volume":"109","year":"2011","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/j.vhri.2016.01.003_bib11","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ajmg.a.32320","article-title":"Mucopolysaccharidoses in Brazil: what happens from birth to biochemical diagnosis?","volume":"146A","author":"Vieira","year":"2008","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.vhri.2016.01.003_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2008","journal-title":"Eur J Pediatr"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109916000066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109916000066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T17:23:51Z","timestamp":1536859431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109916000066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":12,"alternative-id":["S2212109916000066"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2016.01.003","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of the Quantification of Enzymatic Activity in Leukocytes in Comparison to Its Nonrealization for a Rare Disease in Latin America: The Case of Mucopolysaccharidosis Type II in Colombia","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2016.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}